Literature DB >> 3414718

Monitoring of drug-drug and drug-food interactions.

S M Garabedian-Ruffalo1, M Syrja-Farber, P M Lanius, A Plucinski.   

Abstract

A program for detecting and preventing potentially serious drug-drug and drug-food interactions is described. Two clinical pharmacists developed drug interaction alert (DIA) cards for each potential interaction to be monitored. The cards contain information about the proposed mechanism and potential result of the interaction, as well as information about how to monitor or circumvent the interaction. Staff pharmacists check for the occurrence of potential interactions daily as they verify the filling of the patient-medication cassettes; a poster of all the interactions that are included in the program is posted in each satellite pharmacy to serve as a quick reference for the pharmacists. When a pharmacist detects a potential interaction, he or she completes a DIA card and places it in the medication cassette drawer (if the notice is directed to the nurse) or on the front of the patient's chart (if the notice is directed to the physician). The program was introduced to hospital personnel through inservice education programs and departmental newsletters. The results of a quality assurance review indicated that 95 of 279 (34%) cards dispensed to nurses and 40 of 49 (82%) cards dispensed to physicians resulted in some form of action. The program to detect and prevent potentially serious drug-drug and drug-food interactions has been successful.

Entities:  

Mesh:

Year:  1988        PMID: 3414718

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

Review 1.  Important drug-nutrient interactions in the elderly.

Authors:  J A Thomas; R A Burns
Journal:  Drugs Aging       Date:  1998-09       Impact factor: 3.923

Review 2.  Drug-food interactions in hospitalised patients. Methods of prevention.

Authors:  I Gauthier; M Malone
Journal:  Drug Saf       Date:  1998-06       Impact factor: 5.606

Review 3.  Minimising treatment-associated risks in systemic cancer therapy.

Authors:  Ulrich Jaehde; Andrea Liekweg; Sven Simons; Martina Westfeld
Journal:  Pharm World Sci       Date:  2007-09-29

4.  The role of clinical pharmacists in educating nurses to reduce drug-food interactions (absorption phase) in hospitalized patients.

Authors:  Mohammad Abbasi Nazari; Jamshid Salamzadeh; Giti Hajebi; Benjamin Gilbert
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.